Tradeshift, a supply...

Source: Streetwise Reports   04/23/2020

Global healthcare packaging components manufacturer company West Pharmaceutical Services Inc. (WST:NYSE) today announced financial results for its first quarter ending March 31, 2020 and provided updated full-year 2020 financial guidance.

The company reported that net sales in Q1/20 increased to $491.5 million, a 10.8% increase from $443.5 million in Q1/19. During the same corresponding period, the firm stated that non-GAAP diluted earnings per share (EPS) increased by 36% to $0.99 and non-GAAP adjusted-diluted EPS increased by 36% to $1.01.

West Pharmaceutical Services advised that it is maintaining its FY/20 net sales guidance, which is expected to be in a range of $1.95-1.97 billion. The company stated that it is updating FY/20 adjusted-diluted EPS guidance to a new range of $3.52-3.62, compared to the prior estimated range of $3.45-3.55.

The company's President and CEO Eric M. Green commented, "During these unprecedented times, our priorities are focused on the well-being and safety of our team members as well as ensuring the supply of critical, high-quality components and solutions to our customers...I am extremely pleased that we delivered a strong performance in the first quarter given the challenging environment that the COVID-19 pandemic has had on our customers, our suppliers and our team members. In particular, we continued to deliver strong sales growth in high-value products, as demand trends from our worldwide customer base were similar to trends we saw last year. Our teams are partnering with a broad range of customers working to support efforts to develop solutions that address the global COVID-19 pandemic such as diagnostics, anti-viral therapeutics and vaccines."

The firm outlined sales in the most recent quarter by product line. The company reported that in Q1/20, net sales in its Proprietary Products segment grew by 9.7% to $373.5 million and that this segment "saw good demand for Westar^®, Daikyo^®, NovaPure^® and FluroTec^® components as well as for devices such as Daikyo Crystal Zenith^® syringes and cartridges and our self-injection platforms."

The firm noted that net sales from its Contract-Manufactured Products segment grew by 14.5% to $118.1 million led by sales of components for diagnostic devices and drug-injection delivery devices.

The company added that the Biologics market unit enjoyed double-digit organic sales growth, the Generics market unit achieved high-single digit organic sales growth and the Pharma market unit registered mid-single digit organic sales growth.

The firm additionally noted that during Q1/20 under its share repurchase program, it repurchased 761,500 shares for $115.5 million at an average share price of $151.65.

West Pharmaceutical Services is headquartered in Exton, Pa., roughly 35 miles west of Philadelphia, and is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems.

West Pharmaceutical has market capitalization of around $13.5 billion with approximately 73.84 million shares outstanding. WST shares opened 5.25% higher today at $179.05 (+$8.93, +5.25%) over yesterday's $170.12 closing price and reached a new 52-week high price this morning of $190.27. The stock has traded today between $177.13 and $190.27 per share and is currently trading at $187.04 (+$17.17, +10.11%).

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

( Companies Mentioned: WST:NYSE, )

Source: Streetwise Reports   05/06/2020

Biopharmaceutical company Horizon Therapeutics Inc. (HZNP:NASDAQ), which focuses on developing and commercializing medicines for treatment of rare and rheumatic diseases, today announced its Q1/20 financial results for the period ending March 31, 2020. The firm began by advising that it is raising its FY/20 net sales guidance and revised its adjusted EBITDA guidance.

For Q1/20 the company reported that net sales increased by 27% to $355.9 million over Q1/19. The firm provided a breakdown of revenue by business unit and listed that in Q1/20 compared with Q1/19, its Orphan segment net sales increased 47% to $245.4 Million, KRYSTEXXA® net sales rose by 78% to $93.3 million and TEPEZZA (teprotumumab-trbw) net sales were $23.5 million, which exceeded expectations.

The firm advised that it is increasing FY/20 net sales guidance to $1.40-1.45 billion driven primarily by significantly higher TEPEZZA net sales and reflecting anticipated impacts from COVID-19. The company also presented revised FY/20 adjusted EBITDA guidance of $450-500 million, which reflects increased TEPEZZA program investment to support higher-than-expected demand.

The firm indicated that in Q1/20 it posted a GAAP net loss of $13.6 million with adjusted EBITDA of $107.2 million and non-GAAP net income of $83.2 million.

The company's Chairman, President and CEO Timothy Walbert commented, "We had a very strong start to 2020, highlighted by the early approval and rapid uptake of TEPEZZA, which significantly exceeded expectations, excellent KRYSTEXXA growth and our recent acquisition of HZN-825...We are increasing our full-year net sales guidance to account for significantly higher TEPEZZA net sales that more than offset the expected impact from COVID-19 this year, and we are widening both our net sales and adjusted EBITDA guidance ranges to account for future uncertainty. The fundamentals of our business are strong, including a robust cash position, and we continue to be very well positioned for the long term."

The company noted that it received FDA approval for TEPEZZA for the treatment of thyroid eye disease (TED) earlier this year in January. The firm described TED as "a rare, serious, progressive and vision-threatening autoimmune disease, and is associated with proptosis (eye bulging), diplopia (double vision), blurred vision, pain and facial disfigurement." The company further s explained that "TEPEZZA, a fully human monoclonal antibody insulin-like growth factor-1 receptor (IGF-1R) inhibitor, is the first and only FDA-approved medicine for the treatment of TED."

Horizon Therapeutics is a biopharmaceutical company headquartered in Dublin, Ireland. The firm researches, develops and commercializes medicines for treatment of rare and rheumatic diseases.

Horizon has a market capitalization of around $7.1 billion with approximately 190.2 million shares outstanding and a short interest of about 4.9%. HZNP shares opened 10% higher today at $44.19 (+$3.81, +10.19%) over yesterday's $37.38 closing price and reached a new 52-week high price this morning of $43.57. The stock has traded today between $40.00 and $43.90 per share and is currently trading at $42.95 (+$5.57, +14.90%).

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

Damage caused by boats anchoring in seagrass meadows off the coast of Sardinia continues despite restrictions, new research shows. The study's authors provide a number of recommendations to help protect seagrass. These include creating special anchoring areas in seagrass-free locations, and limiting the number of boats that enter a marine protected area.

Pollination studies have, to date, focused almost entirely on bees , butterflies and hoverflies; however, other kinds of flies also have an important role to play in this vital ecosystem service, a new study suggests. Using data from 33 farms, the researchers found that non-hover flies were in fact responsible for carrying 84% of the pollen transferred by flies between flowers in farmland.

New research has produced a starch-based bioplastic with similar properties to equivalent traditional oil-based plastics. By adding an ammonium salt to thermoplastic starch (TPS) the study demonstrated an improvement in the plasticisation process, rendering it flexible, mouldable and potentially recyclable.

A method has been developed to compare how EU Member States have implemented the Energy Performance Buildings Directive. It suggests that implementation varies widely across Europe but that the Czech Republic, Finland, Portugal and Slovakia have kept to the Directive’s aims and guidelines most closely, based on data available in 2009.

New research from Sweden identifies the characteristics of substance flow analyses that make them useful to policy makers. Substance flow analyses that focus on measuring rather than modelling pollution and which are aligned to existing measures are more likely to influence policy.

For more than 120 years the Venus Table of the Dresden Codex -- an ancient Mayan book containing astronomical data -- has been of great interest to scholars around the world. The accuracy of its observations, especially the calculation of a kind of 'leap year' in the Mayan Calendar, was deemed an impressive curiosity used primarily for astrology.

read more

A team of psychologists, kinesiologists and archaeologists at Indiana University and elsewhere are throwing new light on a longstanding archaeological mystery: the purpose of a large number of spherical stone artifacts found at a major archaeological site in South Africa.

read more

Lucy, the most famous fossil of a human ancestor, probably died after falling from a tree, according to a study appearing in Nature led by researchers at The University of Texas at Austin.

read more

Millions of years ago, Africa's savannas were covered with thick, ancient forests, which disappeared and turned into the grassy ecosystems that they are today.

read more

An international team of scientists has described a rare fossil site that is believed to be among the earliest evidence of different fish species using a common nursery -- much like ones utilized by some fish today.

read more

New research in France has analysed the effectiveness of legal instruments and environmental assessments to protect natural areas against the impacts of roads. The Natura 2000 network appears to be the most effective, but the study calls for environmental assessments to take place earlier on in decision-making process for road projects to better protect natural areas.

Patients with cancer have heightened risks of unintentional and intentional injuries during the diagnostic process, reveal findings from a large study published by The BMJ today.

read more

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

read more

University of Oregon researchers have found links between the levels of antimicrobial chemicals and antibiotic-resistance genes in the dust of an aging building used for athletics and academics.

read more

For the first time, abnormal brain development following a Zika infection during pregnancy has been documented experimentally in the offspring of a non-human primate.

read more

Biochar is increasingly mixed into farm soils to improve crop productivity and maintain carbon stocks. However, it can change the way that pesticides applied to the same soil behave, according to a new study. The researchers suggest that farmers may also need to follow new guidelines on pesticide application if they add biochar to their soil.

Widespread use of antibiotics to prevent and treat infections in people and animals as well as for promoting growth in livestock is causing environmental contamination. A new study highlights the need for extra measures to reduce environmental pollution from antibiotics. Such pollution can increase the risk of diseases caused by bacteria that become resistant to antibiotics.

Contrary to some established views, the local animal population is unlikely to be the major source of resistance diversity for Salmonella Typhimurium DT104 in humans in Scotland, according to a study. The researchers suggest that a broader approach to fighting antibiotic resistance is needed, which goes beyond focusing solely on curbing the use of antibiotics in domestic animal populations.

A recent pan-European study has reviewed the factors which influence how annoyed a person feels about road traffic and aircraft noise. Among its findings, residents in terraced housing or apartments were less annoyed by road traffic noise than residents in semi-detached or detached housing.

Dry soils and a lack of cloud cover help explain a major heatwave in France, concludes new research. The study indicates that the two drivers were separate, unlinked events that came together at the same time to worsen the 2006 heatwave. Its findings could allow heatwaves to be predicted more accurately to protect public health.

The application to crops of struvite (magnesium ammonium phosphate) recovered from waste water may cause antibiotic resistance genes (ARGs) present in this fertiliser to enter the food chain. Chinese researchers who conducted this study on Brassica plants suggest that ARGs in struvite pass from the soil into the roots of the plant, and from the roots to the leaves, via the bacterial community already present. The results of this research highlight the need for struvite production methods and agricultural practices that minimise the risk of antibiotic-resistance transmission from struvite to humans or animals via the environment.

A recent report has reviewed research on the effectiveness of low-noise road surfaces, taking into account acoustic performance, safety, skidding resistance and cost. It concludes they could have substantial acoustic and financial benefits, but their durability and safety must be taken into account.

A new study has assessed the annoyance caused by a combination of noises typically found on an industrial site. The results could help improve total noise annoyance prediction models. For example, it was found that ‘broadband’ noises, which consist of a wide range of frequencies, lead to more annoyance if they are combined with a specific additional set of low frequency noises, which can lead to an overall identical noise level.

A recent pan-European study has reviewed the factors which influence how annoyed a person feels about road traffic and aircraft noise. Among its findings, residents in terraced housing or apartments were less annoyed by road traffic noise than residents in semi-detached or detached housing.

New research undertaken in Greece has demonstrated that although 90 per cent of people believe climate change is related to fossil fuel consumption, only half think that biofuels could be an effective solution. The findings have important policy implications for the public acceptance of biofuels.

New research identifies important influences on the energy and environmental performance of biofuels made from agricultural crops. Type of land use change, type of biofuel crop and the by-products from the conversion process all influence performance.

Researchers have demonstrated that hatching in polar cod can begin as early as January in Arctic seas that receive large freshwater input, compared to April-July in seas with little freshwater input. Since early hatching leads to higher survival rates, the effects of climate change may enhance polar cod’s survival by favouring conditions that allow winter hatching to occur.

A report has revealed that the plastic components of waste electrical and electronic equipment (WEEE) can contain significant amounts of hazardous substances, such as lead, mercury or certain flame retardants. The findings suggest that the plastics from some types of WEEE need to be treated as hazardous waste by waste managers and recyclers.

Recycling ships for scrap is a known asbestos exposure hazard, yet this study is one of few to trace asbestos-related cancer rates in shipbreaking workers. The results, obtained from former shipbreakers in Taiwan, show higher rates of cancer overall, especially oesophageal and lung cancers.

Green roofs have been proposed to mitigate flooding in urban areas. This study combined field experiments and numerical simulations to investigate the ability of green roofs to absorb rainwater. The authors describe how green roofs can be most effective at mitigating flooding, providing findings which will be important for policy on green infrastructure.

"The importance of hybrid cloud and AI has accelerated. What has changed is the pace at which they're being adopted. Transformation journeys (of) last few years are now being compacted into months...They're looking for long lasting answers on what they can do with technology to address the key issues that COVID-19 has brought to light," he said.

IT company Cognizant announced it will acquire Collaborative Solutions, a privately-held global consultancy specialising in Workday enterprise cloud applications for finance and HR.

General acceptance of offshore wind farms is most positively influenced by reductions in fossil fuel imports and contributions to global warming mitigation, and most negatively by concerns about increases in electricity price and impacts on scenic views, US research suggests. Other factors, such as reductions in air pollution, were not closely related to general acceptance even though on average the public rated them as important.

Wind energy will likely continue to play a leading role in reaching the EU’s renewable energy targets. However, in some areas wind turbines face social opposition based in large part on the visual impact of wind turbines in the landscape. A new study outlines a novel methodology to measure emotional response to wind turbine visuals, which may assist wind farm planners in gauging public acceptance.

Adding nanoparticles to water in solar collectors, which are used to capture the sun’s energy, can considerably improve their performance, a recent study on nanofluids has found. The energy efficiency of the collector can be increased by up to 76.6% when using water containing 0.1% by volume of titanium dioxide nanoparticles, compared with water alone.

Amid the covid 19 crisis, the Global Inhouse Centre of Canadian financial services company, Sun Life Financial Asia Service Centre India, is baselining projects that can be accelerated, re-scoped and deferred.

The insurance company is planning to make more investments in digital selling and workforce management, thus eyeing the covid-19 situation as an opportunity to strengthen the digital posture than a business challenge.

Quasars are supermassive black holes that sit at the center of enormous galaxies, accreting matter. They shine so brightly that they are often referred to as beacons and are among the most-distant objects in the universe that we can currently study. New work from a team led by Carnegie's Eduardo Bañados has discovered 63 new quasars from when the universe was only a billion years old. (It's about 14 billion years old today.)

read more

The EU Waste Framework Directive aims to recycle or recover materially 70% of non-hazardous construction and demolition waste by 2020. This study evaluated the performance of the Finnish waste management system against this target. The results showed that the system generates environmental benefits and is profitable, but has not reached the 70% target. The researchers suggest ways the target could be met and recommend region-specific recycling objectives in the EU.

A tax of €0.05–0.27 per kilogram (kg) of fertiliser could help to limit French farmers’ use of fertiliser, which is driven by the high rapeseed prices resulting from biofuels policy, according to new economics research. This, in turn, may limit fertilisers’ environmental impacts, such as water pollution, the study’s authors suggest.

A team of Italian scientists has published a study highlighting the important role of intersectoral linkages and eco-innovations in shaping industry’s environmental performance (a measure of its ability to meet environmental targets and objectives) across Europe. The research indicates that eco-innovation can produce positive effects, both directly (in the sector where it is developed) and indirectly (in linked sectors at home and abroad). These insights are relevant to corporate and policy governance strategies aimed at maximising the environmental and economic potential of novel green technologies.

An increasing number of US adults are using marijuana, as fewer people perceive the drug as harmful, according to a survey of over 500000 US adults conducted between 2002 and 2014 published in The Lancet Psychiatry. As marijuana has become increasingly potent over the past decade, the authors say that the findings suggest the need for improved education and prevention messages regarding the risks of marijuana.

read more

The mobility solution brings till to the consumer in the store and enables closure of the entire billing and payment process where consumers are.

Quick Claim Settlement will enable the company to settle claims of up to Rs. 20,000/- and release the settlement amount within 30 minutes in customer’s bank account.

The insurance company is planning to make more investments in digital selling and workforce management, thus eyeing the covid-19 situation as an opportunity to strengthen the digital posture than a business challenge.